首页> 外文期刊>Trials >Evaluation of the impact of levothyroxine treatment on the psychomotor developmental status of three-year-old children born to mothers with mild thyroid impairment; Tehran Thyroid and pregnancy study: study protocol for a randomized clinical trial
【24h】

Evaluation of the impact of levothyroxine treatment on the psychomotor developmental status of three-year-old children born to mothers with mild thyroid impairment; Tehran Thyroid and pregnancy study: study protocol for a randomized clinical trial

机译:评价左旋甲基素治疗对患有轻度甲状腺损伤的三岁儿童精神发育状况的影响;德黑兰甲状腺和妊娠书:随机临床试验的研究方案

获取原文
       

摘要

Despite the known adverse effects of maternal overt hypothyroidism on the neurocognitive development of children, there is uncertainty regarding the impact of gestational thyroid dysfunction or autoimmune thyroiditis on infant/child neurological development. This study aims to evaluate the impact of levothyroxine (LT4) treatment on the psychomotor developmental status of three-year-old children born to mothers with mild thyroid impairment (subclinical hypothyroidismwith/without autoimmune thyroiditis). This is a follow-up study of the Tehran Thyroid and Pregnancy Study, a randomized trial in which subclinical hypothyroid pregnant women were assigned to an intervention group (treated with levothyroxine) or a control group (received no treatment). The primary outcome for the purpose of the present study is the developmental status of the children, aged three years, in five domains (communication, gross motor, fine motor, problem-solving, and social-personal domains) using the Ages and Stages Questionnaire (ASQ). The study is designed to assess the developmental status of children born to mothers with mild thyroid impairment (subclinical hypothyroidism with/without autoimmune thyroiditis). This study is one of the limited studies available in this field and has the potential to facilitate much-needed information for related public health policies. Iranian Registry of Clinical Trials, IRCT2017090314849N5 . Registered on 11 September 2017. Iranian Registry of Clinical Trials, IRCT2017090414849N6 . Registered on 14 October 2017.
机译:尽管母亲明显甲状腺功能亢进对儿童的神经认知发展的危害不良影响,但对妊娠甲状腺功能障碍或自身免疫性甲状腺炎对婴儿/儿童神经发育的影响存在不确定性。本研究旨在评估左旋噻嗪(LT4)治疗对患有轻度甲状腺损伤(亚临床甲状腺功能亢进的母亲)的三岁儿童精神发育状况的影响(亚临床甲状腺炎/没有自身免疫性甲状腺炎)。这是德黑兰甲状腺和妊娠研究的后续研究,其中一项随机试验,其中亚临床甲状腺孕妇妇女被分配给干预组(用左羟基嗪处理)或对照组(未收到任何治疗)。本研究目的的主要结果是使用年龄和阶段问卷的五个域名(沟通,电机,精美电机,问题解决方案,解决和社会私人域名)的三年增长的儿童发展状况(ASQ)。该研究旨在评估以温和的甲状腺损伤(具有/不含自身免疫性甲状腺炎的亚临床甲状腺功能亢进)出生于母亲的儿童的发育状况。本研究是该领域的有限研究之一,有可能促进相关公共卫生政策的急需信息。伊朗注册临床试验,IRCT2017090314849N5。 2017年9月11日注册。临床试验伊朗注册机构,IRCT2017090414849N6。 2017年10月14日注册。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号